Bryan Reynaldo Perez

Array ( [id] => 5160422 [patent_doc_number] => 20070173466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Methods of treating inflammatory diseases associated with bone destruction' [patent_app_type] => utility [patent_app_number] => 10/549474 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8452 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173466.pdf [firstpage_image] =>[orig_patent_app_number] => 10549474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7183556 [patent_doc_number] => 20040203117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells' [patent_app_type] => new [patent_app_number] => 10/487949 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3909 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203117.pdf [firstpage_image] =>[orig_patent_app_number] => 10487949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687742 [patent_doc_number] => 20080031923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Biologic Replacement for Fibrin Clot' [patent_app_type] => utility [patent_app_number] => 10/548159 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 51546 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031923.pdf [firstpage_image] =>[orig_patent_app_number] => 10548159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7092249 [patent_doc_number] => 20050010967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'SK3-1B GFP transgenic mouse model for spinocerebellar ataxia and hyperexcitable behavior' [patent_app_type] => utility [patent_app_number] => 10/791316 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9442 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20050010967.pdf [firstpage_image] =>[orig_patent_app_number] => 10791316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473572 [patent_doc_number] => 20040199934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Transgenic rodents as animal moldels for modulation of b1 bradykinin receptor protein' [patent_app_type] => new [patent_app_number] => 10/487331 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12046 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20040199934.pdf [firstpage_image] =>[orig_patent_app_number] => 10487331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346723 [patent_doc_number] => 20040192630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Vectors having both isoforms of beta-hexosaminidase and uses of the same' [patent_app_type] => new [patent_app_number] => 10/781142 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 72940 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10781142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7336813 [patent_doc_number] => 20040132675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method for treating cancer and increasing hematocrit levels' [patent_app_type] => new [patent_app_number] => 10/467509 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17093 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132675.pdf [firstpage_image] =>[orig_patent_app_number] => 10467509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428204 [patent_doc_number] => 20040209315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Methods to identify agents that increase or decrease UBP43 activity and methods for use of such agents' [patent_app_type] => new [patent_app_number] => 10/771951 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15847 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209315.pdf [firstpage_image] =>[orig_patent_app_number] => 10771951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7007095 [patent_doc_number] => 20050172349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Genetic modification of C57 mice' [patent_app_type] => utility [patent_app_number] => 10/768350 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6259 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20050172349.pdf [firstpage_image] =>[orig_patent_app_number] => 10768350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7189974 [patent_doc_number] => 20040204338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action' [patent_app_type] => new [patent_app_number] => 10/758775 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8193 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204338.pdf [firstpage_image] =>[orig_patent_app_number] => 10758775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6985952 [patent_doc_number] => 20050155097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Eosinophil-deficient transgenic animals' [patent_app_type] => utility [patent_app_number] => 10/755599 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7830 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20050155097.pdf [firstpage_image] =>[orig_patent_app_number] => 10755599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627227 [patent_doc_number] => 07135611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Compositions and methods for characterizing and regulating Wnt pathways' [patent_app_type] => utility [patent_app_number] => 10/755594 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10173 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135611.pdf [firstpage_image] =>[orig_patent_app_number] => 10755594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252538 [patent_doc_number] => 20040259229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Novel technology for genetic mapping' [patent_app_type] => new [patent_app_number] => 10/481364 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20790 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259229.pdf [firstpage_image] =>[orig_patent_app_number] => 10481364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630566 [patent_doc_number] => 07132527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Promoter and plasmid system for genetic engineering' [patent_app_type] => utility [patent_app_number] => 10/739542 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12366 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132527.pdf [firstpage_image] =>[orig_patent_app_number] => 10739542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7419634 [patent_doc_number] => 20040177396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Transgenic animal transformed using green fluorescent protein gene' [patent_app_type] => new [patent_app_number] => 10/480467 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2900 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20040177396.pdf [firstpage_image] =>[orig_patent_app_number] => 10480467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317752 [patent_doc_number] => 20040224408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'THAP proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation' [patent_app_type] => new [patent_app_number] => 10/733878 [patent_app_country] => US [patent_app_date] => 2003-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 129441 [patent_no_of_claims] => 212 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224408.pdf [firstpage_image] =>[orig_patent_app_number] => 10733878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 738236 [patent_doc_number] => 07034201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Developmental animal model of temporal lobe epilepsy' [patent_app_type] => utility [patent_app_number] => 10/728357 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6124 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034201.pdf [firstpage_image] =>[orig_patent_app_number] => 10728357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7343591 [patent_doc_number] => 20040191839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Methods for sorting undifferentiated cells and uses thereof' [patent_app_type] => new [patent_app_number] => 10/719702 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4540 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191839.pdf [firstpage_image] =>[orig_patent_app_number] => 10719702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6974147 [patent_doc_number] => 20050039223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Knock-in-mouse' [patent_app_type] => utility [patent_app_number] => 10/717373 [patent_app_country] => US [patent_app_date] => 2003-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6378 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20050039223.pdf [firstpage_image] =>[orig_patent_app_number] => 10717373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 907846 [patent_doc_number] => 07332644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Non-human animal model of oligodendrocyte developmental disorder' [patent_app_type] => utility [patent_app_number] => 10/712118 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9219 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332644.pdf [firstpage_image] =>[orig_patent_app_number] => 10712118 [rel_patent_id] =>[rel_patent_doc_number] =>)